Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Atossa Therapeutics, Inc.

Clinical trials sponsored by Atossa Therapeutics, Inc., explained in plain language.

Atossa Therapeutics, Inc. ATOS NASDAQ

Clinical-stage biopharmaceutical company developing therapies for breast cancer and other conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New pill combo shows promise in halting Hormone-Fueled breast tumors

Disease control Ongoing

This study tests whether a daily pill (Z-endoxifen) plus a monthly shot (goserelin) can slow or stop estrogen-driven breast cancer growth in premenopausal women. About 87 participants will take the drugs for up to 24 weeks before surgery. The main goal is to see if the treatment …

Phase: PHASE2 • Sponsor: Atossa Therapeutics, Inc. • Aim: Disease control

Last updated Jul 10, 2026 00:00 UTC